HilleVax, Inc.
HLVX
$1.86
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 25.91M | 28.79M | 29.87M | 30.26M | 29.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 80.09M | 106.96M | 135.87M | 143.40M | 138.86M |
| Operating Income | -80.09M | -106.96M | -135.87M | -143.40M | -138.86M |
| Income Before Tax | -106.50M | -147.27M | -150.28M | -156.27M | -143.51M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -106.50 | -147.27 | -150.28 | -156.27 | -143.51 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -106.50M | -147.27M | -150.28M | -156.27M | -143.51M |
| EBIT | -80.09M | -106.96M | -135.87M | -143.40M | -138.86M |
| EBITDA | -78.42M | -105.08M | -134.04M | -141.71M | -137.52M |
| EPS Basic | -2.84 | -3.69 | -3.09 | -3.39 | -3.29 |
| Normalized Basic EPS | -1.03 | -1.37 | -1.68 | -1.86 | -1.89 |
| EPS Diluted | -2.85 | -3.69 | -3.10 | -3.39 | -3.30 |
| Normalized Diluted EPS | -1.03 | -1.37 | -1.68 | -1.86 | -1.89 |
| Average Basic Shares Outstanding | 198.13M | 196.61M | 194.58M | 184.24M | 173.01M |
| Average Diluted Shares Outstanding | 198.13M | 196.61M | 194.58M | 184.24M | 173.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |